Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking gabapentin alongside Wegovy (semaglutide) does not appear to cause a direct pharmacokinetic interaction between the two drugs — neither is metabolised through the liver's cytochrome P450 system, so each tends to clear the body through separate pathways. That said, combining them raises practical questions worth discussing carefully with a prescriber before starting either medicine or adjusting doses. Wegovy is a prescription-only medicine requiring clinical assessment; your suitability, and any medicines you already take, must be reviewed by a qualified clinician before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most concern about drug interactions centres on the liver enzymes that process medicines, if two drugs compete for the same enzyme, one can build up to higher-than-intended levels. Gabapentin sidesteps that entirely: it reaches the bloodstream through a specific intestinal transporter and exits through the kidneys without hepatic metabolism. Semaglutide, the active ingredient in Wegovy, is a peptide broken down by the same biological machinery that handles any protein. There is no shared metabolic pathway to create a classical interaction.
Where the picture becomes more nuanced is at the gut level. Semaglutide slows gastric emptying, that is central to how it reduces appetite. For medicines that depend on intestinal absorption, this delay can push peak blood levels later than usual. The evidence on gabapentin specifically is limited, but its absorption is already somewhat unpredictable at higher doses (gabapentin uptake is saturable, meaning the gut can only take in so much at once). If you are taking gabapentin three times a day, timing your doses away from meals and monitoring for any change in your usual effect is a reasonable precaution to raise with your GP or prescriber. The NHS medicines information for semaglutide notes that slowed gastric emptying is expected with this class of treatment.
The practical upshot: the interaction is theoretical and absorption-related rather than dangerous in the way that, say, two drugs raising heart rate together would be. Still, "theoretical" does not mean ignorable, particularly at higher gabapentin doses.
A question our prescribers hear most weeks is some version of: "I already feel a bit wobbly on gabapentin, will Wegovy make that worse?" It is a fair concern. Gabapentin's most common side effects include dizziness, drowsiness and coordination difficulties. Wegovy's profile is dominated by gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) but fatigue and headache also appear on the list.
Where the two medicines overlap is in fatigue and, for some people, dizziness. This does not mean the combination is prohibited; it means that if you start Wegovy while taking gabapentin and find the dizziness or tiredness meaningfully worse than before, that is useful information for your prescriber rather than something to push through alone. Dehydration from Wegovy-related nausea can compound gabapentin's sedating effects, so staying well hydrated in the first weeks of treatment matters more than usual.
People using gabapentin for nerve pain, epilepsy or anxiety should be especially attentive here: blurred judgement about whether a symptom is a gabapentin side effect or a Wegovy one can delay appropriate adjustments to either medicine. You can explore the broader picture of medicines and supplements to approach carefully alongside semaglutide if you are on multiple prescriptions.
The decision tree here is straightforward. Before starting Wegovy, list every medicine you take (including gabapentin, its dose and how often) on your consultation form. A prescriber can then assess whether your gabapentin dose or timing might need adjustment, check your kidney function context (relevant to both medicines), and set clear guidance on what to watch for.
If you are already on Wegovy and your GP is considering gabapentin, the conversation runs in reverse: tell the GP you are taking semaglutide and ask whether the dose schedule should account for delayed absorption. For a full picture of which drugs require particular caution when taken with Wegovy, including prescription medicines across several categories, that dedicated guide is a useful starting point. The NHS medicines pages and the relevant Summary of Product Characteristics (available through the electronic Medicines Compendium) both confirm that drug interactions should be discussed with a healthcare professional before combining any prescription medicines.
For broader context on what Wegovy costs through a private clinic and what is included in a regulated service, the Wegovy pricing guide sets out the full picture, including prescription, clinical review and aftercare. If you are weighing up whether Wegovy suits your situation at all, the semaglutide overview covers eligibility and the evidence behind the medicine.
Interactions with other commonly prescribed medicines (statins and Wegovy, for instance) follow a similar pattern of being largely manageable with the right clinical oversight rather than being absolute contraindications. If you are also considering an over-the-counter weight loss aid, our guide on whether you can take Alli alongside Wegovy explains the specific considerations involved. The key is that oversight actually happening, from a prescriber with full sight of your medication list. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber, and your medicines history is part of that review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.